Detalhe da pesquisa
1.
Genome-wide aggregated trans-effects on risk of type 1 diabetes: A test of the "omnigenic" sparse effector hypothesis of complex trait genetics.
Am J Hum Genet;
110(6): 913-926, 2023 06 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37164005
2.
Cardiovascular risk management among individuals with type 2 diabetes and severe mental illness: a cohort study.
Diabetologia;
67(6): 1029-1039, 2024 Jun.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38409440
3.
Flash monitor initiation is associated with improvements in HbA1c levels and DKA rates among people with type 1 diabetes in Scotland: a retrospective nationwide observational study.
Diabetologia;
65(1): 159-172, 2022 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-34618177
4.
Development and validation of a cardiovascular risk prediction model in type 1 diabetes.
Diabetologia;
64(9): 2001-2011, 2021 09.
Artigo
em Inglês
| MEDLINE
| ID: mdl-34106282
5.
The association of polypharmacy and high-risk drug classes with adverse health outcomes in the Scottish population with type 1 diabetes.
Diabetologia;
64(6): 1309-1319, 2021 06.
Artigo
em Inglês
| MEDLINE
| ID: mdl-33608768
6.
Marked improvements in glycaemic outcomes following insulin pump therapy initiation in people with type 1 diabetes: a nationwide observational study in Scotland.
Diabetologia;
64(6): 1320-1331, 2021 06.
Artigo
em Inglês
| MEDLINE
| ID: mdl-33686483
7.
Quantitative levels of serum N-glycans in type 1 diabetes and their association with kidney disease.
Glycobiology;
31(5): 613-623, 2021 06 03.
Artigo
em Inglês
| MEDLINE
| ID: mdl-33245334
8.
Relation of severe COVID-19 in Scotland to transmission-related factors and risk conditions eligible for shielding support: REACT-SCOT case-control study.
BMC Med;
19(1): 149, 2021 06 23.
Artigo
em Inglês
| MEDLINE
| ID: mdl-34158021
9.
Relation of severe COVID-19 to polypharmacy and prescribing of psychotropic drugs: the REACT-SCOT case-control study.
BMC Med;
19(1): 51, 2021 02 22.
Artigo
em Inglês
| MEDLINE
| ID: mdl-33612113
10.
PRF1 mutation alters immune system activation, inflammation, and risk of autoimmunity.
Mult Scler;
27(9): 1332-1340, 2021 08.
Artigo
em Inglês
| MEDLINE
| ID: mdl-33566725
11.
Predicting renal disease progression in a large contemporary cohort with type 1 diabetes mellitus.
Diabetologia;
63(3): 636-647, 2020 03.
Artigo
em Inglês
| MEDLINE
| ID: mdl-31807796
12.
Time trends in deaths before age 50 years in people with type 1 diabetes: a nationwide analysis from Scotland 2004-2017.
Diabetologia;
63(8): 1626-1636, 2020 08.
Artigo
em Inglês
| MEDLINE
| ID: mdl-32451572
13.
Comparison of serum and urinary biomarker panels with albumin/creatinine ratio in the prediction of renal function decline in type 1 diabetes.
Diabetologia;
63(4): 788-798, 2020 04.
Artigo
em Inglês
| MEDLINE
| ID: mdl-31915892
14.
Rapid Epidemiological Analysis of Comorbidities and Treatments as risk factors for COVID-19 in Scotland (REACT-SCOT): A population-based case-control study.
PLoS Med;
17(10): e1003374, 2020 10.
Artigo
em Inglês
| MEDLINE
| ID: mdl-33079969
15.
Genome-Wide Association Study of Diabetic Kidney Disease Highlights Biology Involved in Glomerular Basement Membrane Collagen.
J Am Soc Nephrol;
30(10): 2000-2016, 2019 10.
Artigo
em Inglês
| MEDLINE
| ID: mdl-31537649
16.
Biomarker panels associated with progression of renal disease in type 1 diabetes.
Diabetologia;
62(9): 1616-1627, 2019 09.
Artigo
em Inglês
| MEDLINE
| ID: mdl-31222504
17.
Glycaemic control trends in people with type 1 diabetes in Scotland 2004-2016.
Diabetologia;
62(8): 1375-1384, 2019 08.
Artigo
em Inglês
| MEDLINE
| ID: mdl-31104095
18.
The effect of dapagliflozin on glycaemic control and other cardiovascular disease risk factors in type 2 diabetes mellitus: a real-world observational study.
Diabetologia;
62(4): 621-632, 2019 04.
Artigo
em Inglês
| MEDLINE
| ID: mdl-30631892
19.
Incidence of Hospitalization for Heart Failure and Case-Fatality Among 3.25 Million People With and Without Diabetes Mellitus.
Circulation;
138(24): 2774-2786, 2018 12 11.
Artigo
em Inglês
| MEDLINE
| ID: mdl-29950404
20.
Use of personalised risk-based screening schedules to optimise workload and sojourn time in screening programmes for diabetic retinopathy: A retrospective cohort study.
PLoS Med;
16(10): e1002945, 2019 10.
Artigo
em Inglês
| MEDLINE
| ID: mdl-31622334